Abstract
Since the mid-1990s Hydrogen Isotope Exchange (HIE), consisting in the direct exchange of protium with its isotopes, has witnessed an enormous development (Atzrodt et al. in Angew Chem Int Ed, 57:3022–3047, 2018, [1], Atzrodt in Angew Chem Int Ed, 46:7744–7765, 2007, [2]). HIE reactions can nowadays be performed on a plethora of organic compounds by using both homogeneous and heterogeneous catalysis. Molecular catalysts remain the most commonly used due to their high reliability (Atzrodt et al. in Angew Chem Int Ed, 57:3022–3047, 2018, [1]). However, metallic nanoparticles have started attracting the attention of the scientific community (Asensio et al. in Chem Rev, 120:1042–1084, 2020, [3]) because of their interesting characteristics such as:
-
1.
their reactivity in between homogeneous and heterogeneous catalysts,
-
2.
the possibility to deeply influence their chemical properties by varying the stabilizing agent,
-
3.
the non-negligible advantages of (generally) simple workup procedures.
In this chapter, we will give an overview of the recent advances in HIE. First, we will describe the main applications of protium isotopes. Then, we will briefly discuss the main advances in catalytic HIE reactions in both homogeneous and heterogeneous phase. Finally, we will summarize the examples of HIE catalyzed by metallic nanoparticles that have been described in the literature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Atzrodt J, Derdau V, Kerr WJ, Reid M (2018) C-H functionalisation for hydrogen isotope exchange. Angew Chem Int Ed 57:3022–3047
Atzrodt J, Derdau V, Fey T, Zimmermann J (2007) The renaissance of H/D exchange. Angew Chem Int Ed Engl 46:7744–7765
Asensio JM, Bouzouita D, van Leeuwen PWNM, Chaudret B (2020) σ-H–H, σ-C–H, and σ-Si–H bond activation catalyzed by metal nanoparticles. Chem Rev 120:1042–1084. https://doi.org/10.1021/acs.chemrev.1029b00368
Atzrodt J, Derdau V, Kerr WJ, Reid M (2018) Deuterium- and tritium-labelled compounds: applications in the life sciences. Angew Chem Int Ed 57:1758–1784
Urey HC, Brickwedde FG, Murphy GM (1932) A hydrogen isotope of mass 2. Phys Rev 39:164–165
O’Leary D (2012) The deeds to deuterium. Nat Chem 4:236
Oliphant ML, Harteck P (1934) Rutherford transmutation effects observed with heavy hydrogen. Nature 133:413
Lucas LL, Unterweger MP (2000) Comprehensive review and critical evaluation of the half-life of tritium. J Res Natl Inst Stand Technol 105:541–549
Atkins PW, De Paula J (2014) Atkins’ physical chemistry
Wiberg KB (1955) The deuterium isotope effect. Chem Rev 55:713–743
Westheimer FH (1961) The magnitude of the primary kinetic isotope effect for compounds of hydrogen and deuterium. Chem Rev 61:265–273
Klinman JP (2010) A new model for the origin of kinetic hydrogen isotope effects. J Phys Org Chem 23:606–612
Nelson SD, Trager WF (2003) The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. Drug Metab Dispos 31:1481–1498
Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650
Chowdhury G, Calcutt MW, Nagy LD, Guengerich FP (2012) Oxidation of methyl and ethyl nitrosamines by cytochrome P450 2E1 and 2B1. Biochemistry 51:9995–10007
Howland RH (2015) Aspergillus, angiogenesis, and obesity: the story behind beloranib. J Psychosoc Nurs Ment Health Serv 53:13–16
Katsnelson A (2013) Heavy drugs draw heavy interest from pharma backers. Nat Med 19:656
Sanderson K (2009) Big interest in heavy drugs. Nature 458:269
Yarnell A, Wang L (2009) Student affiliates answer presidential video challenge. Chem Eng News 87:48
Mullard A (2017) FDA approves first deuterated drug. Nat Rev Drug Discov 16:305
Stokvis E, Rosing H, Beijnen JH (2005) Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 19:401–407
Hewavitharana AK (2011) Matrix matching in liquid chromatography-mass spectrometry with stable isotope labelled internal standards-Is it necessary? J Chromatogr A 1218:359–361
Berg T, Karlsen M, Oeiestad AML, Johansen JE, Liu H, Strand DH (2014) Evaluation of 13C- and 2H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1344:83–90
Metcalfe C, Tindale K, Li H, Rodayan A, Yargeau V (2010) Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Environ Pollut 158:3179–3185
Piper T, Emery C, Saugy M (2011) Recent developments in the use of isotope ratio mass spectrometry in sports drug testing. Anal Bioanal Chem 401:433–447
Piper T, Thomas A, Thevis M, Saugy M (2012) Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. Drug Test Anal 4:717–727
Tran NH, Hu J, Ong SL (2013) Simultaneous determination of PPCPs, EDCs, and artificial sweeteners in environmental water samples using a single-step SPE coupled with HPLC-MS/MS and isotope dilution. Talanta 113:82–92
Benijts T, Dams R, Lambert W, De Leenheer A (2004) Countering matrix effects in environmental liquid chromatography-electrospray ionization tandem mass spectrometry water analysis for endocrine disrupting chemicals. J Chromatogr A 1029:153–159
Maguire JJ, Kuc RE, Davenport AP (2012) Radioligand binding assays and their analysis. Methods Mol Biol 897:31–77
Harrell AW, Sychterz C, Ho MY, Weber A, Valko K, Negash K (2015) Interrogating the relationship between rat in vivo tissue distribution and drug property data for > 200 structurally unrelated molecules. Pharmacol Res Perspect 3. e00173/00171-e00173/00112
Voges R, Heys JR, Moenius T (2009) Preparation of compounds labeled with tritium and carbon-14
Uttamsingh V, Gallegos R, Liu JF, Harbeson SL, Bridson GW, Cheng C, Wells DS, Graham PB, Zelle R, Tung R (2015) Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine. J Pharmacol Exp Ther 354:43–54
Crabtree R (1979) Iridium compounds in catalysis. Acc Chem Res 12:331–337
Heys R (1992) Investigation of iridium hydride complex [IrH2(Me2CO)2(PPh3)2]BF4 as a catalyst of hydrogen isotope exchange of substrates in solution. J Chem Soc Chem Commun, 680–681
Brown JA, Irvine S, Kennedy AR, Kerr WJ, Andersson S, Nilsson GN (2008) Highly active iridium(I) complexes for catalytic hydrogen isotope exchange. Chem Commun, 1115–1117
Atzrodt J, Derdau V, Kerr WJ, Reid M, Rojahn P, Weck R (2015) Expanded applicability of iridium(I) NHC/phosphine catalysts in hydrogen isotope exchange processes with pharmaceutically-relevant heterocycles. Tetrahedron 71:1924–1929
Valero M, Weck R, Guessregen S, Atzrodt J, Derdau V (2018) Highly selective directed iridium-catalyzed hydrogen isotope exchange reactions of aliphatic amides. Angew Chem Int Ed 57:8159–8163
Kerr WJ, Mudd RJ, Reid M, Atzrodt J, Derdau V (2018) Iridium-catalyzed Csp3-H activation for mild and selective hydrogen isotope exchange. ACS Catal 8:10895–10900
Cochrane AR, Irvine S, Kerr WJ, Reid M, Andersson S, Nilsson GN (2013) Application of neutral iridium(I) N-heterocyclic carbene complexes in ortho-directed hydrogen isotope exchange. J Labell Compd Radiopharm 56:451–454
Kerr WJ, Reid M, Tuttle T (2015) Iridium-catalyzed C-H activation and deuteration of primary sulfonamides: an experimental and computational study. ACS Catal 5:402–410
Kerr WJ, Reid M, Tuttle T (2017) Iridium-catalyzed formyl-selective deuteration of aldehydes. Angew Chem Int Ed 56:7808–7812
Prechtl MHG, Hoelscher M, Ben-David Y, Theyssen N, Loschen R, Milstein D, Leitner W (2007) H/D exchange at aromatic and heteroaromatic hydrocarbons using D2O as the deuterium source and ruthenium dihydrogen complexes as the catalyst. Angew Chem Int Ed 46:2269–2272
Hale LVA, Szymczak NK (2016) Stereoretentive deuteration of α-chiral amines with D2O. J Am Chem Soc 138:13489–13492
Maegawa T, Fujiwara Y, Inagaki Y, Monguchi Y, Sajiki H (2008) A convenient and effective method for the regioselective deuteration of alcohols. Adv Synth Catal 350:2215–2218
Fujiwara Y, Iwata H, Sawama Y, Monguchi Y, Sajiki H (2010) Method for regio-, chemo- and stereoselective deuterium labeling of sugars based on ruthenium-catalyzed C-H bond activation. Chem Commun 46:4977–4979
Gao L, Perato S, Garcia-Argote S, Taglang C, Martinez-Prieto LM, Chollet C, Buisson D-A, Dauvois V, Lesot P, Chaudret B et al (2018) Ruthenium-catalyzed hydrogen isotope exchange of C(sp3)-H bonds directed by a sulfur atom. Chem Commun 54:2986–2989
Ma S, Villa G, Thuy-Boun PS, Homs A, Yu J-Q (2014) Palladium-catalyzed ortho-selective C-H deuteration of arenes: evidence for superior reactivity of weakly coordinated palladacycles. Angew Chem Int Ed 53:734–737
Yang H, Dormer PG, Rivera NR, Hoover AJ (2018) Palladium(II)-mediated C-H tritiation of complex pharmaceuticals. Angew Chem Int Ed 57:1883–1887
Maegawa T, Akashi A, Esaki H, Aoki F, Sajiki H, Hirota K (2005) Efficient and selective deuteration of phenylalanine derivatives catalyzed by Pd/C. Synlett, 845–847
Sajiki H, Esaki H, Aoki F, Maegawa T, Hirota K (2005) Palladium-catalyzed base-selective H-D exchange reaction of nucleosides in deuterium oxide. Synlett, 1385–1388
Yu PR, Hesk D, Rivera N, Pelczer I, Chirik PJ (2016) Nature. Nature Publishing Group vol 529, pp 195–199
Palmer WN, Chirik PJ (2017) Cobalt-catalyzed stereoretentive hydrogen isotope exchange of C(sp3)-H bonds. ACS Catal 7:5674–5678
Yang H, Zarate C, Palmer WN, Rivera N, Hesk D, Chirik PJ (2018) Site-selective nickel-catalyzed hydrogen isotope exchange in N-heterocycles and Its application to the tritiation of pharmaceuticals. ACS Catal 8:10210–10218
Zarate C, Yang H, Bezdek MJ, Hesk D, Chirik PJ (2019) Ni(I)-X complexes bearing a bulky α-diimine ligand: synthesis, structure, and superior catalytic performance in the hydrogen isotope exchange in pharmaceuticals. J Am Chem Soc 141:5034–5044
Pla D, Gomez M (2016) Metal and metal oxide nanoparticles: a lever for C-H functionalization. ACS Catal 6:3537–3552
Ott LS, Cline ML, Deetlefs M, Seddon KR, Finke RG (2005) Nanoclusters in ionic liquids: evidence for N-Heterocyclic carbene formation from imidazolium-based ionic liquids detected by 2H NMR. J Am Chem Soc 127:5758–5759
Sullivan JA, Flanagan KA, Hain H (2008) Selective H-D exchange catalyzed by aqueous phase and immobilized Pd nanoparticles. Catal Today 139:154–160
Guy KA, Shapley JR (2009) H-D exchange between N-heterocyclic compounds and D2O with a Pd/PVP colloid catalyst. Organometallics 28:4020–4027
Pan C, Pelzer K, Philippot K, Chaudret B, Dassenoy F, Lecante P, Casanove M-J (2001) Ligand-stabilized ruthenium nanoparticles: synthesis, organization, and dynamics. J Am Chem Soc 123:7584–7593
Pery T, Pelzer K, Buntkowsky G, Philippot K, Limbach H-H, Chaudret B (2005) Direct NMR evidence for the presence of mobile surface hydrides on ruthenium nanoparticles. Chem Phys Chem 6:605–607
Breso-Femenia E, Godard C, Claver C, Chaudret B, Castillón S (2015) Selective catalytic deuteration of phosphorus ligands using ruthenium nanoparticles: a new approach to gain information on ligand coordination. Chem Commun 51:16342–16345
Pieters G, Taglang C, Bonnefille E, Gutmann T, Puente C, Berthet J-C, Dugave C, Chaudret B, Rousseau B (2014) Regioselective and stereospecific deuteration of bioactive aza compounds by the use of ruthenium nanoparticles. Angew Chem Int Ed 53:230–234
Taglang C, Martinez-Prieto LM, del Rosal I, Maron L, Poteau R, Philippot K, Chaudret B, Perato S, Sam Lone A, Puente C et al. (2015) Enantiospecific C-H activation using ruthenium nanocatalysts. Angew Chem Int Ed 54:10474–10477
Martínez-Prieto LM, Baquero EA, Pieters G, Flores JC, de Jesús E, Nayral C, Delpech F, van Leeuwen PWNM, Lippens G, Chaudret B (2017) Monitoring of nanoparticle reactivity in solution: interaction of l-lysine and Ru nanoparticles probed by chemical shift perturbation parallels regioselective H/D exchange. Chem Commun 53:5850–5853
Bhatia S, Spahlinger G, Boukhumseen N, Boll Q, Li Z, Jackson JE (2016) Stereoretentive H/D exchange via an electroactivated heterogeneous catalyst at sp3 C-H sites bearing amines or alcohols. Eur J Org Chem 2016:4230–4235
Bouzouita D, Lippens G, Baquero EA, Fazzini PF, Pieters G, Coppel Y, Lecante P, Tricard S, Martinez-Prieto LM, Chaudret B (2019) Tuning the catalytic activity and selectivity of water-soluble bimetallic RuPt nanoparticles by modifying their surface metal distribution. Nanoscale 11:16544–16552
Palazzolo A, Feuillastre S, Pfeifer V, Garcia-Argote S, Bouzouita D, Tricard S, Chollet C, Marcon E, Buisson D-A, Cholet S et al. (2019) Efficient access to deuterated and tritiated nucleobase pharmaceuticals and oligonucleotides using hydrogen-isotope exchange. Angew Chem Int Ed 58:4891–4895
Rothermel N, Bouzouita D, Roether T, de Rosal I, Tricard S, Poteau R, Gutmann T, Chaudret B, Limbach H-H, Buntkowsky G (2018) Surprising differences of alkane C-H activation catalyzed by ruthenium nanoparticles: complex surface-substrate recognition? Chem Cat Chem 10:4243–4247
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Palazzolo, A., Asensio, J.M., Bouzouita, D., Pieters, G., Tricard, S., Chaudret, B. (2020). Metal Nanoparticles for Hydrogen Isotope Exchange. In: van Leeuwen, P., Claver, C. (eds) Recent Advances in Nanoparticle Catalysis. Molecular Catalysis, vol 1. Springer, Cham. https://doi.org/10.1007/978-3-030-45823-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-45823-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45822-5
Online ISBN: 978-3-030-45823-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)